Anavex Life Sciences Corp (AVXL)

[Investor2014]

That paper, if worth its salt, will also establish that the ADCS-ADL co-primary endpoint failed and thus that the all endpoints met statement was false.

Anavex and everyone else but the class action lawyers can now hope that approval and/or some other reason results in a share price increase making any action moot.

I don’t think we will see that peer reviewed paper until Anavex and their lawyers feel certain that the risk of litigation has hopefully subsided.